Moreover, aberrant IL-1 signalling, and IL-1-related gene polymorphisms are implicated in the pathogenesis of BS, and anti-IL-1 therapies have shown some efficacy in the treatment of refractory BS [22,23,24,25,26]. The gene discussed is IL1B; the disease is Bloom syndrome.